These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33693906)

  • 1. White Matter Neurometabolic Signatures Support the Deficit and Nondeficit Distinction in Antipsychotic-Naïve First-Episode Psychosis Patients.
    Bryant JE; Lahti AC; Briend F; Kraguljac NV
    Schizophr Bull; 2021 Jul; 47(4):1068-1076. PubMed ID: 33693906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study.
    de la Fuente-Sandoval C; León-Ortiz P; Azcárraga M; Stephano S; Favila R; Díaz-Galvis L; Alvarado-Alanis P; Ramírez-Bermúdez J; Graff-Guerrero A
    JAMA Psychiatry; 2013 Oct; 70(10):1057-66. PubMed ID: 23966023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis.
    Bojesen KB; Ebdrup BH; Jessen K; Sigvard A; Tangmose K; Edden RAE; Larsson HBW; Rostrup E; Broberg BV; Glenthøj BY
    Psychol Med; 2020 Oct; 50(13):2182-2193. PubMed ID: 31524118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting Frontoparietal Network Connectivity in Antipsychotic Medication-Naive First-Episode Psychosis Patients Who Do and Do Not Display Features of the Deficit Syndrome.
    King VL; Lahti AC; Maximo JO; Ver Hoef LW; John S; Kraguljac NV
    Schizophr Bull; 2022 Nov; 48(6):1344-1353. PubMed ID: 35869578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study.
    Plitman E; Chavez S; Nakajima S; Iwata Y; Chung JK; Caravaggio F; Kim J; Alshehri Y; Chakravarty MM; De Luca V; Remington G; Gerretsen P; Graff-Guerrero A
    Psychiatry Res Neuroimaging; 2018 Mar; 273():16-24. PubMed ID: 29414127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.
    Plitman E; de la Fuente-Sandoval C; Reyes-Madrigal F; Chavez S; Gómez-Cruz G; León-Ortiz P; Graff-Guerrero A
    Schizophr Bull; 2016 Mar; 42(2):415-24. PubMed ID: 26320195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurometabolic abnormalities in the associative striatum in antipsychotic-naïve first episode psychosis patients.
    Sivaraman S; Kraguljac NV; White DM; Morgan CJ; Gonzales SS; Lahti AC
    Psychiatry Res Neuroimaging; 2018 Nov; 281():101-106. PubMed ID: 30286325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reward disturbances in antipsychotic-naïve patients with first-episode psychosis and their association to glutamate levels.
    Tangmose K; Rostrup E; Bojesen KB; Sigvard A; Jessen K; Johansen LB; Glenthøj BY; Nielsen MØ
    Psychol Med; 2023 Mar; 53(4):1629-1638. PubMed ID: 37010221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive brain structural changes after the first year of treatment in first-episode treatment-naive patients with deficit or nondeficit schizophrenia.
    Lei W; Kirkpatrick B; Wang Q; Deng W; Li M; Guo W; Liang S; Li Y; Zhang C; Li X; Zhang P; Li Z; Xiang B; Chen J; Hu X; Zhang N; Li T
    Psychiatry Res Neuroimaging; 2019 Jun; 288():12-20. PubMed ID: 31059954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroimaging evidence for the deficit subtype of schizophrenia.
    Voineskos AN; Foussias G; Lerch J; Felsky D; Remington G; Rajji TK; Lobaugh N; Pollock BG; Mulsant BH
    JAMA Psychiatry; 2013 May; 70(5):472-80. PubMed ID: 23467781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurometabolic correlates of 6 and 16 weeks of treatment with risperidone in medication-naive first-episode psychosis patients.
    Birur B; Kraguljac NV; VerHoef L; Morgan CJ; Jindal RD; Reid MA; Luker A; Lahti AC
    Transl Psychiatry; 2020 Jan; 10(1):15. PubMed ID: 32066680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurometabolic and functional changes of default-mode network relate to clinical recovery in first-episode psychosis patients: A longitudinal
    Li W; Xu J; Xiang Q; Zhuo K; Zhang Y; Liu D; Li Y
    Neuroimage Clin; 2022; 34():102970. PubMed ID: 35240468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamatergic Metabolites, Volume and Cortical Thickness in Antipsychotic-Naive Patients with First-Episode Psychosis: Implications for Excitotoxicity.
    Plitman E; Patel R; Chung JK; Pipitone J; Chavez S; Reyes-Madrigal F; Gómez-Cruz G; León-Ortiz P; Chakravarty MM; de la Fuente-Sandoval C; Graff-Guerrero A
    Neuropsychopharmacology; 2016 Sep; 41(10):2606-13. PubMed ID: 27272768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features.
    Garcia-Rizo C; Fernandez-Egea E; Oliveira C; Justicia A; Bernardo M; Kirkpatrick B
    Psychiatry Res; 2012 Jul; 198(2):212-5. PubMed ID: 22405656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade.
    Ebdrup BH; Raghava JM; Nielsen MØ; Rostrup E; Glenthøj B
    J Psychiatry Neurosci; 2016 Mar; 41(2):133-41. PubMed ID: 26599135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis.
    de la Fuente-Sandoval C; León-Ortiz P; Favila R; Stephano S; Mamo D; Ramírez-Bermúdez J; Graff-Guerrero A
    Neuropsychopharmacology; 2011 Aug; 36(9):1781-91. PubMed ID: 21508933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prefrontal and Striatal Gamma-Aminobutyric Acid Levels and the Effect of Antipsychotic Treatment in First-Episode Psychosis Patients.
    de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Jung-Cook H; Solís-Vivanco R; Graff-Guerrero A; Shungu DC
    Biol Psychiatry; 2018 Mar; 83(6):475-483. PubMed ID: 29132653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia.
    Reid MA; White DM; Kraguljac NV; Lahti AC
    Schizophr Res; 2016 Feb; 170(2-3):341-50. PubMed ID: 26718333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early treatment response in first episode psychosis: a 7-T magnetic resonance spectroscopic study of glutathione and glutamate.
    Dempster K; Jeon P; MacKinley M; Williamson P; Théberge J; Palaniyappan L
    Mol Psychiatry; 2020 Aug; 25(8):1640-1650. PubMed ID: 32205866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of hippocampal metabolism and regional brain grey matter in neuroleptic-naïve ultra-high-risk subjects and first-episode schizophrenia.
    Nenadic I; Maitra R; Basu S; Dietzek M; Schönfeld N; Lorenz C; Gussew A; Amminger GP; McGorry P; Reichenbach JR; Sauer H; Gaser C; Smesny S
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1661-8. PubMed ID: 26088723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.